In a study using a transgenic APP/PS1 mouse model of Alzheimer’s disease, TargetScanTM analysis identified a potential binding site for miR-204-3p in the 3′-UTR of NOX4 [71]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.